A First-in-human Study to Learn About the Safety of BAY 3547926 and How Well it Works in Participants With Advanced Liver Cancer

Clinical trial NCT06764316 · RECRUITING

Trial details

NCT number: NCT06764316
Sponsor: Bayer
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Hepatocellular Carcinoma

Start date: 2025-02-28
Primary completion: 2029-07-31
Enrollment: 148

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.